Book a Demo

Please select a preferred date(s) and time(s):

    Contact Sales

      By clicking "Submit" you agree to our Privacy Policy

      CertiScan®: Adherence Matters


      USE CASE

      Improve Decentralized Trials

      Simple solutions for medication data collection and remote management.

      Our products eliminate some of the challenges associated with decentralized trials, without introducing any new challenges themselves.
      We help participants focus on their treatment and not the technology. Our solutions operate in the background, freeing the patient to focus on their health.
      Improve Decentralized Trials

      Solutions

      Automatic Dose Tracking
      automatic dose tracking
      We make blistered and bottled smart packaging that automatically records each dose. Dose data can viewed instantly (for real-time use cases), or stored on the smart package for up 3 years later (for retrospective use cases). All devices are manufactured in ISO/GMP compliant facilities.
      Remote Management
      remote management
      Our web portal lets researchers monitor participants and make sure they are engaged and active in a study. The mobile app help participants build and stick to a routine. Present protocol-specific schedules that guide participants through their daily activities, including medication reminders, various alerts, and notifications about upcoming appointments (whether in-person or virtual).
      Replaces Documentation
      handling and pickup
      Dosing data is inherently accurate and automatically synchronizes with a central database. No need to double check, transcribe, or decipher illegible handwriting. It is also acquired remotely, and unlike paperwork, it does not need to be returned to a site for handling or processing.

      Specific Benefits

      Passive, Background Operation

      Our monitoring and alerting features work automatically without blocking trial procedures or adding new burdens or processes.

      Serves as a REMS

      The FDA requires risk estimation and mitigation strategy for trials where drugs pose serious risks, such as opioids. Our solutions and automated timely interventions can form a key part of your REMS.

      Potential for Fewer Blood Draws

      For path-setting trials: use adherence as a measure of plasma concentration, in order to reduce (but never replace) blood draw activities.

      Prevent Unnecessary Continuation

      Failure to collect and act on adherence data means trials overrecruit and track participants for longer in order to drown out the statistical impacts. This results in potentially months of delay in getting to market.

      Monitor Engagement

      Use participant adherence as a barometer of trial engagement, to make sure that they are following the protocol, and take interventions if not.

      Fewer Participants, Same Power

      Basing final PK and PD analysis on a more selective group of highly adherent participants can yield the same power despite having a smaller number. This selective group can be achieved either by adapting enrollment or by stratifying data post hoc.

      Learn More about the Products
      that Power our Solutions

      med-ic

      Med-ic®

      The original smart blister package. Breaking a blister records the time and location (i.e. “8:00 a.m.” and “Day 1, Morning”). Med-ic® can be customized to work with any blister design and dose pattern.
      ecap-updated

      eCap™

      The superior smart cap. Unscrewing and removing the eCap™ records the opening time. Several diameter and threading options are available to fit all common bottle types.

      CertiScan® Platform

      Consumer-quality software for clinical trials. Securely store, analyze, and action the data from smart packaging and other adherence devices. The CertiScan® Platform includes web portals, mobile apps, developer tools, and a secure, central cloud.

      Did You Know?

      drug development
      Data handling and pickup costs can account for up to 30% of drug development costs. Smart packaging solutions can greatly reduce these costs, potentially saving thousands of dollars per participant.
      Med-ic® and eCap™ are unique among DCT products in that they place no additional burden on the participant in terms of handling technology. They do not need to be configured, there is no battery to be recharged or replaced, and they do not change the blister package or bottle in noticeable ways.
      smart packaging
      mobile app
      Our CertiScan® mobile app has been designed thoughtfully to maximize participant convenience and to be as low-burden as our smart packaging. Nevertheless, use of the CertiScan® app is optional, and many of the decentralized benefits of our smart packaging are still available if participants or studies choose not to use the app.
      The FDA requires risk estimation and mitigation strategies - REMS. Our solutions can help address the unique challenges you face conducting REMS in decentralized trials. We empower you to remotely detect and take timely actions on hazards like drug misuse, diversion, tampering, temperature exposure, excursions, and more.
      FDA approved

      ROI

      Our experts have modelled the relationship between statistical power, sample size and medication adherence.
      Their findings? For every 1% adherence increase, there can be a 2% reduction in trial size (N) while holding statistical power constant.
      Considering that many trials currently only reach 50% adherence, there’s lots of room for improvement – and tremendous ROI.
      CRO

      Direct Savings from Reduced N

      Processing a participant is expensive. Requiring a smaller sample size could amount to millions of dollars in savings.
      Drug Development

      Additional Weeks of Patent Protection

      Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.
      enrollment

      Additional Weeks of Patent Protection

      Smaller N means a faster trial, potentially by months. This could amount to tens of millions of dollars in additional revenue.

      Recent Articles

      blog
      Scientific Publications | 16 May 2024

      Independent Study finds eCap™…

      Read More
      blog
      Press Releases | 6 May 2024

      Information Mediary Corp. and…

      PRESS RELEASE May 6, 2024 – New York, NY — Information Mediary Corp (IMC)…

      Read More
      blog
      Blog | 5 May 2024

      Welcome to the new…

      We are thrilled to unveil our revamped website! As you explore our new digital…

      Read More
      blog
      Case Studies | 5 May 2024

      Evaluating Hepatitis C Treatment…

      Overview Direct-Acting Antiviral (DAA) therapy is an effective treatment for hepatitis C. However DAA…

      Read More
      blog
      Whitepapers | 5 May 2024

      Driving Adherence With Smart…

      Read More
      blog
      Press Releases | 4 May 2024

      IMC introduces CertiScan® 2.0

      Att: Health Tech Desk FOR IMMEDIATE RELEASE April 28, 2021 New York, NY Contact:…

      Read More
      More

      Let's Talk

      Our mission is to create adherence-focused technologies that enable safer, faster, more efficient, and more innovative clinical research. There’s an IMC solution that will transform your next trial. Don’t wait, start the conversation with our team now. We’ll reach out in order to:
      • Deeply understand your particular needs.
      • Explore how Med-ic®, eCap™, and CertiScan®, can benefit your study.
      • Work collaboratively to prepare a specific solution that will exceed your expectations.

      Connect with Us

        By clicking "Submit" you agree to our Privacy Policy